Symbol="RIGL"
AssetType="Common Stock"
Name="Rigel Pharmaceuticals Inc"
Description="Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat blood disorders, cancer, and rare immune diseases. The company is headquartered in South San Francisco, California."
CIK="1034842"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1180 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="227504000"
EBITDA="-43376000"
PERatio="None"
PEGRatio="-0.1"
BookValue="-0.14"
DividendPerShare="0"
DividendYield="0"
EPS="-0.25"
RevenuePerShareTTM="0.724"
ProfitMargin="-0.357"
OperatingMarginTTM="-0.356"
ReturnOnAssetsTTM="-0.204"
ReturnOnEquityTTM="-6.99"
RevenueTTM="125077000"
GrossProfitTTM="53721000"
DilutedEPSTTM="-0.25"
QuarterlyEarningsGrowthYOY="0.745"
QuarterlyRevenueGrowthYOY="0.558"
AnalystTargetPrice="4.16"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.556"
PriceToBookRatio="31.64"
EVToRevenue="1.692"
EVToEBITDA="-1.948"
Beta="0.681"
num_52WeekHigh="2.04"
num_52WeekLow="0.668"
num_50DayMovingAverage="1.401"
num_200DayMovingAverage="1.281"
SharesOutstanding="173667000"
DividendDate="None"
ExDividendDate="None"
symbol="RIGL"
open="1.31"
high="1.34"
low="1.29"
price="1.31"
volume="986874.00"
latest_trading_day="2023-07-13"
previous_close="1.30"
change="0.01"
change_percent="0.7692%"
aroon_positive_momentum_days="70"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="70"
Volume_recent_avg="2631904"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="70"
Aroon_momentum_negative="30"
image_negative_thumbnail_id_1="100"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0076.jpeg"
image_negative_thumbnail_id_2="507"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="597"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_positive_thumbnail_id_1="606"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0102.jpeg"
image_positive_thumbnail_id_2="968"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0130.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
